UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000048600
Receipt number R000055381
Scientific Title Effi cacy test of plant extract on sleep dissatisfi ed people
Date of disclosure of the study information 2022/08/05
Last modified on 2023/01/06 18:15:54

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Efficacy test of plant extract on sleep

Acronym

Sleep test

Scientific Title

Effi cacy test of plant extract on sleep dissatisfi ed people

Scientific Title:Acronym

Sleep test

Region

Japan


Condition

Condition

Healthy adults

Classification by specialty

Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Confi rmation of the eff ect of plant extract intake on sleep for sleep dissatisfi ed people

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Indexes on sleeping

Key secondary outcomes

Indexes on sleeping
Questionnaire


Base

Study type

Interventional


Study design

Basic design

Cross-over

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Food

Interventions/Control_1

Intake of a food containing plant extract oncea day for one weeks

Interventions/Control_2

Intake of a placebo food that does not containplant extract once a day for one weeks

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

45 years-old <=

Age-upper limit

65 years-old >

Gender

Male and Female

Key inclusion criteria

-Healthy men and women.
-Subjects who are aware of problems or issues with sleep.
-Subjects who can make self-judgment and arevoluntarily giving written informed consent.

Key exclusion criteria

-Currently receiving treatment (including medication) for any disease
-Subjects who have been diagnosed as having a sleep disorder such as insomnia or sleep apnea syndrome, and are taking drugs such as sleep inducers or insomnia medications (including OTC drugs as well as prescription drugs),or receiving treatment with CPAP or mouthpieces, etc.
-Those who regularly consume foods for specified health uses, foods with functional claims, or other foods/beverages with possible functional properties.
-Subjects with a BMI over 30 (severely obese)
-Subjects who are primarily responsible for the care of persons in need of nursing care or infants.
-All who are unable to sleep alone on a single bedding (e.g., futon or bed) during the study period.
-A person who is not able to comply with the gentle sleep control (going to bed within Plus or minus 2 hours of the reported bedtime and waking up within Plus or minus 2 hours of the reported waking time) during the test period.
-Candidates who cannot avoid drinking alcohol and consuming caffeinated beverages (sencha, black tea, coffee, caffeinated beverages, etc.) after 6:00 p.m. during the EEG measurement period and the day before the measurement period.
-Consistently consumes more than adequate alcohol (average daily alcohol consumption of approximately 20 g of pure alcohol or less).
-Consentee who is unable to complete the EEG measurement and the sleep diary/OSA sleep questionnaire according to the schedule.
-Participants who have participated or will participate in other clinical trials in the month prior to the date of consent
-Other individuals who are deemed by the physician to be inappropriate to participate in the study.

Target sample size

20


Research contact person

Name of lead principal investigator

1st name Yuya
Middle name
Last name Tezuka

Organization

WELLPHARMA Inc.

Division name

research team

Zip code

150-0002

Address

Shibuya 1 and 2F, 2-4-3 Shibuya, Shibuya-ku, Tokyo, 150-0002, Japan

TEL

+81-3-6868-8806

Email

yuya_t@wellpharma.co.jp


Public contact

Name of contact person

1st name Yoko
Middle name
Last name Shimada

Organization

Clinical Creative Co.,Ltd.

Division name

Pharmaceuticals Division

Zip code

061-1121

Address

6-1-3 Central, Kitahiroshima City, Hokkaido, 061-1121, Japan

TEL

+81-11-887-7197

Homepage URL


Email

y-shimada@cli-creative.com


Sponsor or person

Institute

WELLPHARMA Inc.

Institute

Department

Personal name



Funding Source

Organization

WELLPHARMA Inc.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Sapporo yurinokai Hospital

Address

11-186 Yurigahara, Kita-ku, Sapporo, Hokkaido

Tel

+81-11-771-1501

Email

info@yurinokai.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2022 Year 08 Month 05 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2022 Year 06 Month 20 Day

Date of IRB

2022 Year 06 Month 29 Day

Anticipated trial start date

2022 Year 07 Month 07 Day

Last follow-up date

2022 Year 09 Month 30 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2022 Year 08 Month 05 Day

Last modified on

2023 Year 01 Month 06 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000055381


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name